| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970886 | The Journal of Heart and Lung Transplantation | 2011 | 9 Pages |
Abstract
The findings obtained increase the knowledge on the mode of action of rosiglitazone in promoting the survival of MHC Class II-mismatched cardiac transplants in which the CD8 T cells and eosinophils play key roles. PPAR-γ signaling combined with IL-5 blockade prevents graft rejection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yan PhD, Daxu MSc, Julia Yuen Shan PhD, Na PhD, Jiao MSc, Jiang MSc, Kenneth MSc, Aimin PhD, Vincent Chi Hang PhD, Jonathan Robert PhD, Paul Kwong Hang MBBS, ChM,